Chinese English Japanese Korean

Hubei Molcoo Biotechnology Co., Ltd

Firmenname:Hubei Molcoo Biotechnology Co., Ltd
Telefon:-
E-Mail:anna@molcoo.com
Nationalität:China
URL: www.molcoo.com/
Produkte insgesamt:2713
23 24 25 26 27 28

Produktkatalog

Riboflavin-4'-Phosphate; (2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)-1,3,4-trihydroxypentan-2-yl dihydrogen phosphate60697-29-2C17H21N4O9P
Riboflavin83-88-5C17H20N4O6
Quinapril HCl; (S)-2-((S)-2-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride82586-55-8C25H31ClN2O5
Quinapril EP Impurity A; (S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid74163-81-8C10H11NO2
Quinapril EP Impurity C; (S)-2-((S)-2-(((S)-1-carboxy-3-phenylpropyl)amino)propanoyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid82768-85-2C23H26N2O5
Quinapril EP Impurity D; (S)-ethyl 2-((3S,11aS)-3-methyl-1,4-dioxo-3,4,11,11a-tetrahydro-1H-pyrazino[1,2-b]isoquinolin-2(6H)-yl)-4-phenylbutanoate103733-49-9C25H28N2O4
Quinapril EP Impurity E; (S)-2-((S)-2-(((S)-4-cyclohexyl-1-ethoxy-1-oxobutan-2-yl)amino)propanoyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid2055735-09-4C25H36N2O5
Quinapril EP Impurity G; 103775-06-0(HCl);(R)-2-((S)-2-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid103833-16-5C25H30N2O5
rac-Mirogabalin; 2-(6-(aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl)acetic acid1415817-35-4C12H19NO2
Nicardipine Impurity 50; 2-cyanoethyl 2-(3-nitrobenzylidene)-3-oxobutanoate102993-38-4C14H12N2O5
Amisulpride Impurity 53; methyl 4-amino-5-(ethylthio)-2-methoxybenzoate1119455-01-4C11H15NO3S
Pinaverium Bromide Impurity 22; 4-(bromomethyl)-1,2-dimethoxybenzene21852-32-4C9H11BrO2
Dasatinib Impurity 65; 2-amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide302964-24-5C11H10ClN3OS
N-Methoxy-N-Nitroso-Methanamine; N-methoxy-N-methylnitrous amide16339-12-1C2H6N2O2
Indacaterol Impurity 24; (R)-8-(benzyloxy)-5-(2-bromo-1-hydroxyethyl)quinolin-2(1H)-one530084-79-8C18H16BrNO3
Indacaterol Impurity 25(Benzoate); 435273-75-9(free base);(R)-8-(benzyloxy)-5-(2-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino)-1-hydroxyethyl)quinolin-2(1H)-one benzoate753498-24-7C38H40N2O5
Sulfadoxine; 4-amino-N-(5,6-dimethoxypyrimidin-4-yl)benzenesulfonamideSulfadoxin2447-57-6C12H14N4O4S
Sulfadoxine Impurity 2; N-(4-(N-(5,6-dimethoxypyrimidin-4-yl)sulfamoyl)phenyl)acetamide5018-54-2C14H16N4O5S
Sulfadoxine Impurity 3; N-(5,6-dimethoxypyrimidin-4-yl)-4-(methylamino)benzenesulfonamide1346603-39-1C13H16N4O4S
Sulfadoxine Impurity 4; 4-amino-N-(6-hydroxy-5-methoxypyrimidin-4-yl)benzenesulfonamide1346604-08-7C11H12N4O4S
Sulfadoxine Impurity 5; 4-amino-N-(6-chloro-5-methoxypyrimidin-4-yl)benzenesulfonamide5018-23-5C11H11ClN4O3S
Sulfadoxine Impurity 6; 4-amino-N-(6-(dimethylamino)-5-methoxypyrimidin-4-yl)benzenesulfonamide7749-17-9C13H17N5O3S
Pemigatinib; 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholinomethyl)-3,4-dihydro-1H-pyrrolo[3',2':5,6]pyrido[4,3-d]pyrimidin-2(7H)-one1513857-77-6C24H27F2N5O4
Pemigatinib Impurity 6; 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-methyl-8-(morpholinomethyl)-3,4-dihydro-1H-pyrrolo[3',2':5,6]pyrido[4,3-d]pyrimidin-2(7H)-one1513857-61-8C23H25F2N5O4
Edoxaban Impurity 76; tert-butyl ((1S,2R,5S)-2-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamate2024614-15-9C21H30ClN5O5
Edoxaban Impurity 77; tert-butyl ((1R,2R,5S)-2-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamate480451-98-7C21H30ClN5O5
Edoxaban Impurity 78; tert-butyl ((1R,2S,5R)-2-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamate2024614-32-0C21H30ClN5O5
Edoxaban Impurity 79; tert-butyl ((1S,2S,5R)-2-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamate2024614-21-7C21H30ClN5O5
Edoxaban Impurity 80; tert-butyl ((1S,2R,5R)-2-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamate1255529-33-9C21H30ClN5O5
Edoxaban Impurity 81; tert-butyl ((1R,2R,5R)-2-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamate1255529-38-4C21H30ClN5O5
Gefitinib Impurity 47; 4-chloro-7-methoxyquinazolin-6-yl acetate230955-75-6C11H9ClN2O3
Gefitinib Impurity 48; 7-methoxy-4-oxo-3,4-dihydroquinazolin-6-yl acetate179688-53-0C11H10N2O4
Gefitinib Impurity 49; 4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl acetate788136-89-0C17H13ClFN3O3
Gefitinib Impurity 50; 4-(3-((4-chloro-7-methoxyquinazolin-6-yl)oxy)propyl)morpholine199327-59-8C16H20ClN3O3
Gefitinib Impurity 51; 4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile675126-26-8C15H19N3O5
Gefitinib Impurity 52; 3-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4(3H)-one1608115-59-8C22H23ClFN3O4
Vardenafil Impurity 18; 2-(5-((4-(2-hydroxyethyl)piperazin-1-yl)sulfonyl)-2-propoxyphenyl)-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-one1339092-18-0C24H34N6O5S
Alogliptin Impurity 43; 2-((piperidin-3-ylamino)methyl)benzonitrile1354088-25-7C13H17N3
Alogliptin Impurity 44; (R)-2-(((1-(3-(2-cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)amino)methyl)benzonitrile2749424-28-8C26H26N6O2
4-Hydroxy Ramelteon; (S)-N-(2-(4-hydroxy-2,6,7,8-tetrahydro-1H-indeno[5,4-b]furan-8-yl)ethyl)propionamide1204581-50-9C16H21NO3
Ramelteon Metabolite M-II; 2-hydroxy-N-(2-((S)-2,6,7,8-tetrahydro-1H-indeno[5,4-b]furan-8-yl)ethyl)propanamide896736-21-3C16H21NO3
Ramelteon Impurity 43; N-(2-(2,6-dihydro-1H-indeno[5,4-b]furan-8-yl)ethyl)propionamide196597-30-5C16H19NO2
Ramelteon Impurity 44; (S)-N-(2-(4-acetyl-2,6,7,8-tetrahydro-1H-indeno[5,4-b]furan-8-yl)ethyl)propionamide1346598-94-4C18H23NO3
Ramelteon Impurity 45; 6H-indeno[5,4-b]furan-8(7H)-one15480-25-8C11H8O2
Ramelteon Impurity 46; N-(2-(6,7-dihydro-1H-indeno[5,4-b]furan-8(2H)-ylidene)ethyl)propionamide1365920-11-1C16H19NO2
Valsartan Impurity 71; N-(diazirino[1,3-f]phenanthridin-4-ylmethyl)-N-isobutylpentanamide1314799-75-1C23H27N3O
Afatinib Impurity 116; 4-((4-chloro-3-fluorophenyl)amino)-6-nitroquinazolin-7-ol2475094-95-0C14H8ClFN4O3
Afatinib Impurity 117; (S)-N4-(3-chlorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine2413212-09-4C18H17ClN4O2
Afatinib Impurity 118; (S)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)but-3-enamide2413212-17-4C22H20ClFN4O3
Afatinib Impurity 119; (S)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)formamide2223677-60-7C19H16ClFN4O3
Afatinib Impurity 120; (S)-N4-(3,4-difluorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine2044709-72-8C18H16F2N4O2
Afatinib Impurity 121; (S,E)-2-((3-chloro-4-fluorophenyl)(6-(4-(dimethylamino)but-2-enamido)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-4-yl)amino)malonic acid2413212-27-6C27H27ClFN5O7
Trelagliptin Impurity 51; 2-((6-ethoxy-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile1938080-43-3C15H14FN3O3
Trelagliptin Impurity 52; 4-fluoro-2-(hydroxymethyl)benzonitrile1000339-93-4C8H6FNO
Dabigatran Impurity 88; 2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamide1015167-33-5C22H21N7O
Dabigatran Impurity 89; 4-(((5-((2-carboxyethyl)(pyridin-2-yl)carbamoyl)-1-methyl-1H-benzo[d]imidazol-2-yl)methyl)amino)benzoic acid1253792-34-5C25H23N5O5
Dabigatran Impurity 90; hexyl (4-aminobenzoyl)carbamate1899045-28-3C14H20N2O3
Dabigatran Impurity 91; ethyl 3-(2-(((4-(N-((hexan-3-yloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate1610758-22-9C34H41N7O5
Dabigatran Impurity 92; ethyl 2-(((4-carbamoylphenyl)amino)methyl)-1-methyl-1H-benzo[d]imidazole-5-carboxylate1422435-40-2C19H20N4O3
N-Nitroso Azelastine
Mirabeiron Nitroso Impurity 60
Tamoxifen Impurity 22
Nitroso-Desmethyl-Lercanidipine EP Impurity E
Gatifloxacin Nitroso Impurity 255556-94-0C5H10N4O2
Cinitapride Nitroso Impurity 12396758-93-1C10H19N3O3
N-Nitroso Desmethyl Sumatriptan3036581-86-6C13H18N4O3S
N-Nitroso-4-Hydroxypiperidine55556-93-9C5H10N2O2
Dasatinib Nitroso Impurity 662135905-86-9C20H21ClN8O2S
Esmolol Impurity 1583356-60-9C15H22NNaO4
Eperisone Impurity G
N-Nitroso-Desmethyl-Lercanidipine Impurity D
Regadenoson Impurity 1C14H15N7O6
Brompheniramine Impurity 118453-10-6C15H17BrN2
Gatifloxacin Nitroso Impurity 24
Rupatadine EP Impurity C1224515-72-3C45H43Cl2N5
Flunarizine Nitroso Impurity 10
Clomipramine N-oxide14171-67-6C19H23ClN2O
N-Nitroso-Desmethyl-Lercanidipine
N-Nitroso Belumosudil
Palonosetron HCL Impurity ZZ13
N-Nitroso Esmolol Impurity 1
Ataluren Impurity 20
Mirabeiron Nitroso Impurity 58
Buspirone Impurity 20872826-80-7C8H11N5O
Doxylamine Impurity E97143-65-2C17H22N2O2
Regadenoson Impurity 44C12H17N5O5
N-Nitroso Cariprazine Impurity
Doxylamine Impurity F105176-70-3C17H22N2O3
Eicosapentaenoic Acid Impurity 26123940-93-2C22H36O2
Azelastine Impurity 11(Hydrochloride)79342-58-8C21H23Cl2N3O
Olanzapine Thiolactam Impurity1017241-36-9C17H20N4OS
N-Nitroso Sarcosine55332-68-8C3H6N2O3
N-Nitroso Epinephrine3006789-99-4C9H12N2O4
Rupatadine Impurity 25Pyridin-3,5-dicarbonsureC7H5NO4
Tamoxifen N-oxide75504-34-6C26H29NO2
Tamoxifen EP Impurity F(Hydrochloride)15917-65-4C25H27NO.ClH
N-Nitroso Desmethyl Tamoxifen
Azelastine EP Impurity F640279-88-5C22H24ClN3O2
Ozanimod Impurity 481306763-61-0C23H36N2O3Si
Indapamide Impurity A85440-79-5C9H10N2O
23 24 25 26 27 28
Copyright 2019 © ChemicalBook. All rights reserved